# CRE8 in All Comers Patients

> **NCT01687075** · NA · COMPLETED · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 215 (actual)

## Conditions studied

- Consecutive Subjects Who Are Suitable for a Coronary
- Angioplasty of de Novo Lesion(s) in Native Coronary
- Arteries Should be Screened for Eligibility.
- A Total Number of 200 Patients Fulfilling the Selection
- Criteria and Willing to Sign the Informed Consent Should
- be Enrolled in the Trial.

## Interventions

- **DEVICE:** CR8 a drug eluting coronary stent

## Key facts

- **NCT ID:** NCT01687075
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-07
- **Final completion:** 2014-08
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2016-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01687075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01687075, "CRE8 in All Comers Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01687075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*